Mutual of America Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-21,577
Closed -$1.56M 1642
2022
Q1
$1.56M Sell
21,577
-936
-4% -$67.5K 0.02% 1006
2021
Q4
$1.82M Sell
22,513
-210
-0.9% -$21K 0.02% 992
2021
Q3
$2.65M Sell
22,723
-6,130
-21% -$802K 0.03% 854
2021
Q2
$4.78M Sell
28,853
-1,243
-4% -$194K 0.05% 551
2021
Q1
$4.2M Buy
30,096
+11,517
+62% +$1.88M 0.04% 619
2020
Q4
$3.22M Sell
18,579
-388
-2% -$62.8K 0.04% 705
2020
Q3
$2.64M Sell
18,967
-3,245
-15% -$434K 0.04% 683
2020
Q2
$2.65M Sell
22,212
-1,505
-6% -$179K 0.04% 687
2020
Q1
$2.37M Buy
+23,717
New +$2.85M 0.04% 623
2018
Q4
Sell
-60,876
Closed -$3.47M 1717
2018
Q3
$3.47M Sell
60,876
-16,987
-22% -$1.06M 0.05% 615
2018
Q2
$6.22M Buy
77,863
+22,810
+41% +$1.89M 0.09% 275
2018
Q1
$4.77M Hold
55,053
0.07% 406
2017
Q4
$3.8M Buy
55,053
+7,531
+16% +$602K 0.06% 541
2017
Q3
$4.32M Hold
47,522
0.07% 434
2017
Q2
$3.54M Buy
47,522
+23,213
+95% +$1.86M 0.06% 528
2017
Q1
$2.28M Buy
+24,309
New +$2.2M 0.04% 743

Other funds holding NVRO

Mutual of America Capital Management's NVRO Position: Q2 2022 in Review

Mutual of America Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 21,577 shares — an estimated $1.56M sold.

Mutual of America Capital Management first reported a position in NVRO in Q1 2017 and held it in 16 quarters. The position peaked at $6.22M in Q2 2018. 176 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

  • Mutual of America Capital Management reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 21,577 NEVRO CORP. shares in Q2 2022, an estimated $1.56M.
  • Mutual of America Capital Management first reported a position in NEVRO CORP. in Q1 2017 and held it in 16 quarters.
  • Mutual of America Capital Management's NEVRO CORP. position peaked at $6.22M in Q2 2018.
  • 176 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Mutual of America Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.